Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers

Viruses. 2023 Apr 14;15(4):966. doi: 10.3390/v15040966.

Abstract

Background: COVID-19 vaccination or natural infection is associated with the development of immunity. The search of IgA and IgG antibodies against all the structural proteins (spike, nucleocapsid, membrane, and envelope) of SARS-CoV-2 in breastfeeding mothers is associated with immunity that can help the newborn avoid development of the infection. Methods: In this study, we analyzed 30 breastfeeding women that provided samples of breast milk and serum and evaluated the presence of IgA, total IgG, and subclasses against the structural proteins of SARS-CoV-2. Results: We reported a high seroprevalence to IgA (76.67-100%) and negativity to IgG against all analyzed proteins in breast milk. Seroprevalence in serum samples was around 10-36.67% to IgA and 23.3-60% to IgG. Finally, we detected the presence of the subclasses IgG1, IgG2, and IgG4 against all the structural proteins of SARS-CoV-2. Conclusions: This work provides evidence of the presence of IgA and IgG antibodies against the four structural proteins of SARS-CoV-2 in breast milk and serum samples derived from breastfeeding women, which can confer immunity to the newborn.

Keywords: COVID-19; IgA; IgG; SARS-CoV-2; antibodies; breastfeeding; structural proteins.

MeSH terms

  • Antibodies, Viral
  • Breast Feeding
  • COVID-19 Vaccines
  • COVID-19*
  • Female
  • Humans
  • Immunoglobulin A
  • Immunoglobulin G
  • Infant, Newborn
  • Milk, Human*
  • Mothers
  • SARS-CoV-2
  • Seroepidemiologic Studies

Substances

  • Immunoglobulin G
  • COVID-19 Vaccines
  • Immunoglobulin A
  • Antibodies, Viral

Grants and funding

This research received no external funding.